Compile Data Set for Download or QSAR
maximum 50k data
Found 115 Enz. Inhib. hit(s) with all data for entry = 50001655
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50291665(CHEMBL4165327)
Affinity DataIC50:  0.360nMAssay Description:Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ever...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50291432(CHEMBL4159705)
Affinity DataIC50:  2.70nMAssay Description:Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ever...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholinesterase(Equus caballus (Horse))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM8961(1,2,3,4-tetrahydro-9-acridinamine | 1,2,3,4-tetrah...)
Affinity DataIC50:  3.20nMAssay Description:Inhibition of equine serum BChE using butyrylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every mi...More data for this Ligand-Target Pair
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50291438(CHEMBL4161065)
Affinity DataIC50:  10nMAssay Description:Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ever...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50291612(CHEMBL4163678)
Affinity DataIC50:  11nMAssay Description:Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ever...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50291664(CHEMBL4173239)
Affinity DataIC50:  17nMAssay Description:Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ever...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50291633(CHEMBL4165973)
Affinity DataIC50:  18nMAssay Description:Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ever...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50291636(CHEMBL4169938)
Affinity DataIC50:  21nMAssay Description:Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ever...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50291610(CHEMBL4159880)
Affinity DataIC50:  22nMAssay Description:Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ever...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50291635(CHEMBL4162015)
Affinity DataIC50:  24nMAssay Description:Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ever...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50291435(CHEMBL4177133)
Affinity DataIC50:  30nMAssay Description:Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ever...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50291637(CHEMBL4173784)
Affinity DataIC50:  37nMAssay Description:Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ever...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50291436(CHEMBL4168037)
Affinity DataIC50:  43nMAssay Description:Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ever...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50291437(CHEMBL4160115)
Affinity DataIC50:  56nMAssay Description:Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ever...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50291577(CHEMBL4159243)
Affinity DataIC50:  69nMAssay Description:Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ever...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50291434(CHEMBL4166513)
Affinity DataIC50:  71nMAssay Description:Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ever...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50291439(CHEMBL4168987)
Affinity DataIC50:  111nMAssay Description:Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ever...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50291433(CHEMBL4170331)
Affinity DataIC50:  117nMAssay Description:Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ever...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50291575(CHEMBL4165562)
Affinity DataIC50:  144nMAssay Description:Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ever...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50291616(CHEMBL4171568)
Affinity DataIC50:  171nMAssay Description:Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ever...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50291584(CHEMBL4160696)
Affinity DataIC50:  173nMAssay Description:Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ever...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50291568(CHEMBL4176179)
Affinity DataIC50:  210nMAssay Description:Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ever...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50291606(CHEMBL4164981)
Affinity DataIC50:  242nMAssay Description:Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ever...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholinesterase(Equus caballus (Horse))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50291435(CHEMBL4177133)
Affinity DataIC50:  256nMAssay Description:Inhibition of equine serum BChE using butyrylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every mi...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50291630(CHEMBL4175003)
Affinity DataIC50:  275nMAssay Description:Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ever...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50291584(CHEMBL4160696)
Affinity DataIC50:  286nMAssay Description:Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ever...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50291440(CHEMBL4173405)
Affinity DataIC50:  308nMAssay Description:Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ever...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholinesterase(Equus caballus (Horse))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50291568(CHEMBL4176179)
Affinity DataIC50:  341nMAssay Description:Inhibition of equine serum BChE using butyrylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every mi...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholinesterase(Equus caballus (Horse))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50291577(CHEMBL4159243)
Affinity DataIC50:  373nMAssay Description:Inhibition of equine serum BChE using butyrylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every mi...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50291588(CHEMBL4166464)
Affinity DataIC50:  379nMAssay Description:Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ever...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholinesterase(Equus caballus (Horse))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50291437(CHEMBL4160115)
Affinity DataIC50:  412nMAssay Description:Inhibition of equine serum BChE using butyrylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every mi...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50291584(CHEMBL4160696)
Affinity DataIC50:  415nMAssay Description:Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ever...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50291584(CHEMBL4160696)
Affinity DataIC50:  415nMAssay Description:Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ever...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholinesterase(Equus caballus (Horse))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50291438(CHEMBL4161065)
Affinity DataIC50:  433nMAssay Description:Inhibition of equine serum BChE using butyrylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every mi...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholinesterase(Equus caballus (Horse))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50291436(CHEMBL4168037)
Affinity DataIC50:  489nMAssay Description:Inhibition of equine serum BChE using butyrylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every mi...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholinesterase(Equus caballus (Horse))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50291434(CHEMBL4166513)
Affinity DataIC50:  496nMAssay Description:Inhibition of equine serum BChE using butyrylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every mi...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50291505(CHEMBL4172797)
Affinity DataIC50:  556nMAssay Description:Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ever...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50291504(CHEMBL4172353)
Affinity DataIC50:  568nMAssay Description:Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ever...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholinesterase(Equus caballus (Horse))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50291439(CHEMBL4168987)
Affinity DataIC50:  596nMAssay Description:Inhibition of equine serum BChE using butyrylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every mi...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholinesterase(Equus caballus (Horse))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50291664(CHEMBL4173239)
Affinity DataIC50:  665nMAssay Description:Inhibition of equine serum BChE using butyrylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every mi...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50291587(CHEMBL4174372)
Affinity DataIC50:  894nMAssay Description:Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ever...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50291579(CHEMBL4173313)
Affinity DataIC50:  896nMAssay Description:Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ever...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50291617(CHEMBL4160310)
Affinity DataIC50:  923nMAssay Description:Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ever...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholinesterase(Equus caballus (Horse))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50291584(CHEMBL4160696)
Affinity DataIC50:  1.67E+3nMAssay Description:Inhibition of equine serum BChE using butyrylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every mi...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholinesterase(Equus caballus (Horse))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50291665(CHEMBL4165327)
Affinity DataIC50:  1.79E+3nMAssay Description:Inhibition of equine serum BChE using butyrylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every mi...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAcetylcholinesterase(Homo sapiens (Human))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50291580(CHEMBL4170940)
Affinity DataIC50:  1.86E+3nMAssay Description:Inhibition of human erythrocyte AChE using acetylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured ever...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholinesterase(Equus caballus (Horse))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50291616(CHEMBL4171568)
Affinity DataIC50:  2.04E+3nMAssay Description:Inhibition of equine serum BChE using butyrylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every mi...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholinesterase(Equus caballus (Horse))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50291440(CHEMBL4173405)
Affinity DataIC50:  2.17E+3nMAssay Description:Inhibition of equine serum BChE using butyrylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every mi...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholinesterase(Equus caballus (Horse))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50291606(CHEMBL4164981)
Affinity DataIC50:  2.24E+3nMAssay Description:Inhibition of equine serum BChE using butyrylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every mi...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholinesterase(Equus caballus (Horse))
Vfp Therapies

Curated by ChEMBL
LigandPNGBDBM50291608(CHEMBL4170530)
Affinity DataIC50:  2.51E+3nMAssay Description:Inhibition of equine serum BChE using butyrylthiocholine iodide as substrate preincubated for 5 mins followed by substrate addition measured every mi...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 115 total ) | Next | Last >>
Jump to: